Join us at HUPO in Toronto, Canada from November 9 - 13 and listen to our two seminars to learn more about Proteomics and timsTOF technology.
Deep Blood Proteomics to Map the State of the Human Body
Hui Zhang, Ph.D., Professor of Pathology, Oncology, Urology, and Chemical and Biomolecular Engineering, Johns Hopkins University, Baltimore, MD, USA
Exploring non-canonical interactions of G protein-coupled receptors using unbiased proteomics
Ruth Huttenhain, Ph.D., Assistant Professor, Department of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, CA, USA
More to come!
Hui Zhang, Ph.D., Professor of Pathology, Oncology, Urology, and Chemical and Biomolecular Engineering, Johns Hopkins University, Baltimore, MD, USA
Ruth Huttenhain, Ph.D., Assistant Professor, Department of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, CA, USA
Tackling a next frontier in proteomics: template free de novo sequencing of endogenous antibodies enabled by the timsOmni™
Albert Heck, Ph.D., Distinguished Faculty Professor of Chemistry and Pharmaceutical Sciences, Utrecht University and Scientific Director, Netherlands Proteomics Center, Utrecht, Netherlands
Antigen Discovery with High-Sensitivity Immunopeptidomics: From Biologics to (Immuno)Therapy Development
Elise Pepermans, Ph.D., CEO and Co-founder, ImmuneSpec, Antwerp, Belgium
More to come!
Albert Heck, Ph.D., Distinguished Faculty Professor of Chemistry and Pharmaceutical Sciences, Utrecht University and Scientific Director, Netherlands Proteomics Center, Utrecht, Netherlands
Elise Pepermans, Ph.D., CEO and Co-founder, ImmuneSpec, Antwerp, Belgium
As you are certainly aware, special compliance regulations apply to public officials* and healthcare professionals** with regard to the event we are planning. If you accept our invitation, we will therefore assume that you will observe the compliance regulations that apply to you and that you have the necessary employer approval.
* Government Official means according the Bruker policies any of the following: any officer, employee or representative of a government (national, regional or local) entity, or any public agency, public authority, department or instrumentality thereof, regardless of their rank or title (e.g. a regulatory official or government inspector); any person working for or advising a government-owned or government-controlled enterprise (e.g. a professor at a government-owned university, or a purchaser at a government-owned hospital); any person working for or advising a national or international non-governmental organization (e.g. an employee of the Red Cross or The World Bank); any person performing a public function or providing a public service, even if that person works for a nongovernmental institution (e.g. private security personnel working in public functions); any person hired to review or accept bids for a government agency; any person with the responsibility to allocate or expend government funds; any person in a public law function, civil servant, judge or military personnel; any person acting for a political party, including party officials, candidates or individuals holding a position in a political party office; members of royal families; or immediate family members of any of the persons listed above. An immediate family member is a grandparent, parent, spouse, significant other, child, or sibling.
** A Healthcare Professional (HCP) is in accordance with the Bruker policies any physician, dentist, nurse, pharmacist or other individual who may prescribe, administer, purchase, dispense, recommend, or supply medical products or treatments or pharmaceutical products. In many cases, Bruker interacts with HCPs who work for state-owned hospitals (e.g. as medical scientists). These individuals will be classified as both HCPs and Government Officials.
For Research Use Only. Not for use in clinical diagnostic procedures.